Moumita Chatterjee, Ph.D.
Affiliations: | 2011 | Department of Biological Sciences | University of Delaware, Newark, DE, United States |
Area:
Cell Biology, OncologyGoogle:
"Moumita Chatterjee"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Kenneth L. van Golen | grad student | 2011 | University of Delaware | |
| (The role of Rho GTPases in breast cancer dormancy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chatterjee M, Ben-Josef E, Robb R, et al. (2017) Caveolae-Mediated Endocytosis is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy. Cancer Research |
| Williams TM, Chatterjee M, Robb R, et al. (2016) Abstract 405: Caveolin-1 expression mediates response to albumin-bound paclitaxel Cancer Research. 76: 405-405 |
| Banerji B, Chatterjee M, Prodhan C, et al. (2016) Tripeptide consisting of benzyl protected di-cysteine and phenylalanine forms spherical assembly and induces cytotoxicity in cancer cells via apoptosis Rsc Advances. 6: 112667-112676 |
| Estrada-Bernal A, Chatterjee M, Haque SJ, et al. (2015) MEK Inhibitor GSK1120212-Mediated Radiosensitization of Pancreatic Cancer Cells Involves Inhibition of DNA Double-Strand Break Repair Pathways. Cell Cycle (Georgetown, Tex.). 0 |
| Bertino EM, Williams TM, Nana-Sinkam SP, et al. (2015) Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients. Clinical Lung Cancer. 16: 466-474.e4 |
| Chatterjee M, Ben-Josef E, Thomas DG, et al. (2015) Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer. Scientific Reports. 5: 10867 |
| Houghton PJ, Kurmasheva RT, Kolb EA, et al. (2015) Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP). Pediatric Blood & Cancer. 62: 1214-21 |
| Robb RN, Yang L, Chatterjee M, et al. (2015) Abstract C31: Vemurafenib selectively radiosensitizes BRAF V600E mutant papillary and anaplastic thyroid carcinoma cells in vitro Molecular Cancer Therapeutics. 14 |
| Chatterjee M, Vedaie M, Robb R, et al. (2015) Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel Molecular Cancer Therapeutics. 14 |
| Chatterjee M, Williams TM. (2014) Abstract 4702: Caveolin-1 confers a multi-modality therapy resistance phenotype in pancreatic cancer cells Cancer Research. 74: 4702-4702 |